Maximize the probability of your clinical trial success by accelerating patient enrollment and flexible operations
Whether it is investigator-initiated study, observational study, phase 0, 1, 2, 3, or 4 post-market trials, real-world evidence generation to supplement your randomized controlled clinical trial, maximizing the speed of patient enrollment is the proven way to minimize your risk.
We interviewed hundreds of stakeholders of clinical trials
They expressed dissatisfaction and complained about the poor experience with clinical trials.
"Every clinical trial feels like the first-ever trial undertaken by mankind"
"Delays in patient recruitment put the entire clinical trial at risk"
"If there is one thing I could fix, I would maximize the speed of clinical trial"
Reduces the logistical burdens on sites and participants by 70 %
With bi-directional communications, scheduling, eligibility screening, and remote touch-less electronic informed consent, investigators can rapidly enroll participants in clinical studies with participants safely reviewing the study material at their own convenience remotely from their own mobile device.
Combine a la carte tools into a single modular unified platform
We understand technology is a means to an end. We strive to achieve the right balance between the use of technology and expert human intervention to optimize trial operations. Clinical study teams spend hundreds of hours coordinating participants' schedules to ensure quality and compliance.
Accelerate patient recruitment timelines by 3x
Jeeva SaaS streamlines the workflows for eligibility screening, bi-directional communications, and remote electronic informed consents with a focus on accelerating timelines while improving the user experience. We focus on optimizing the study operations so you can focus on research outcomes.
Phase IV studies, post market studies, or longitudinal cohort studies
Longitudinal cohort studies collect clinical, behavioral, lifestyle, and environmental data from participants in real-world settings over extended periods of time. Our bring-your-own-device platform makes it easy for study investigators to onboard, engage, and retain participants. The FDA and NIH's National Center for Advanced Translational Sciences have encouraged patient groups to drive the establishment of high-quality institutional review board (IRB) approved patient registries and natural history studies.
Gene therapy or vaccine trials with long-term follow-up
Gene therapy or vaccine trials typically involve one-time therapy administration with long-term follow-up with patients for safety monitoring. Physical site visit requirements over a long period of time place an undue burden on trial participants. Jeeva simplifies this process by fitting the trial into the lifestyle of patients. Cell and gene therapies are the most advanced form of one-and-done treatments for patients with rare genetic diseases including cancer. FDA guidelines in January 2020 require sponsors of such therapy trials to monitor patients over extended periods of time to better understand the durability of these treatments. Most of the existing clinical trial management or electronic data capture tools were designed for traditional brick-and-mortar clinical trials that usually span less than three years. Our purpose-designed solution for five, 10, or 15-year follow-up studies is the perfect solution for these studies.
Investigator Initiated Trials
Our experienced coordinators provide the highest quality of video conferencing visits for patients and caregivers. Our goal is to help simplify and manage the trial operations to minimize burden, reduce dropouts, improve compliance, and accelerate the development of therapies. Investigator initiated single site studies suffer from lack of funding necessary to conduct certain large-scale, real-world evidence, observational, or drug repurposing studies of medicines already proven safe. Jeeva eClinical cloud platform offers a cost-effective solution to quickly setup and conduct clinical studies of any scale or duration, with or without patient travel involved.